1. The effect of dietary molybdenum on the growth rate and also on ascorbic acid metabolism in rats was studied. An excess of dietary molybdenum resulted in growth retardation and loss of weight. Tolerance to molybdenum was affected by the nature of the molybdenum salt administered. 2. Molybdenum ingestion altered certain aspects of ascorbic acid metabolism in rats. The conversion of D-glucuronolactone into L-ascorbic acid in vitro and the oxidative breakdown of L-ascorbic acid by liver enzymes decreased with high molybdenum intakes. The activity of liver uronolactonase was slightly inhibited. The activities of L-gulonate dehydrogenase and L-gulonate decarboxylase were not affected appreciably. 3. Molybdenum supplementation of the control diet resulted in an increase in ascorbic acid content of spleen and adrenal gland, and in a marked decrease in the urinary excretion of ascorbic acid and glucuronic acid. The implications of these findings are discussed.
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The precise functional role of ascorbic acid in cellular metabolism is not clearly understood, although this vitamin has been found to be involved in the metabolism of various substances. The deprivation of ascorbic acid leads to the development of several metabolic derangements that can be cured by the administration of the vitamin. The interrelationship between minerals and ascorbic acid metabolism has lately been the topic of interest, and a ew preliminary reports have appeared, mainly on the effect of metal ions on the tissue reserve ofthe vitamin in both rats and rabbits (Chatterjee, 1967) . The effect of molybdenum on ascorbic acid metabolism has been investigated by Russian workers, who have noted increased ascorbic acid content in liver, muscles and blood of rats and rabbits after the administration of sodium molybdate or ammonium molybdate orally or by subcutaneous injection (Malevannaya, 1963) . Under conditions of scurvy in guinea pigs, the molybdenum content of the liver is slightly decreased, but it is increased in the bones, with a significant increase in the kidney (Smolinska, 1962) .
From these interesting leads it was thought worth while to study the various aspects of ascorbic acid metabolism in rats and their interrelationships with molybdenum. This paper deals with studies on the liver and the kidney enzymes related to the glucuronic acid pathway of ascorbic acid metabolism (Ashwell, Kanfer, Smiley & Burns, 1961) in an attempt to correlate the interactions between molybdenum and ascorbic acid metabolism.
METHODS
Details of the methods for the determination of total ascorbic acid in tissues and the preparation of rat liver and kidney homogenates, of the incubation media for studying the biosynthesis of L-ascorbic acid, of the test system to study the catabolism of L-ascorbic acid, of the incubation system to study the synthesis of L-xylulose, and of the methods for the determination of uronolactonase activity, protein and glucuronic acid were all given in the preceding paper (Mukherjee, Kar, Sasmal & Chatterjee, 1968) .
Determination of molybdenum in urine. The molybdenum content of the urine was determined by the thiocyanatestannous chloride method (Sandell, 1959) .
Animal experiment8. 1. Feeding of various amounts of molybdenum as sodium molybdate (Na2MoO4,2H20) to rats. Male albino rats weighing 60-80g., which had been maintained on stock diet, were divided into several groups and given the experimental diets ad libitum. The basal diet contained 18% casein, 72-6% corn starch, 5% groundnut oil, 4% Steenbock salt mixture no. 40 (Steenbock & Nelson, 1923) RESULTS Growth studies. The data on the effect of various concentrations of dietary molybdenum on the growth of rats are presented in Fig. 1 . Molybdenum given as ammonium molybdate had a growthdepressing effect even at 500p.p.m. in the diet. Molybdenum when given as the sodium salt at dosages of 500p.p.m. and 1000p.p.m. was without any adverse effect on growth. But at the higher concentrations in the diet molybdenum was found to be toxic to rats irrespective of the nature of the salt used.
Tisue, ascorbic acid concentration8. The data on the storage of the vitamin in liver, kidney, brain, spleen and adrenal gland are presented in Table 1 . The ascorbic acid contents in liver, kidney and brain decreased, with a corresponding increase in contents in spleen and adrenal gland in rats given a high dose of molybdenum. Molybdenum-induced changes of tissue reserves of the vitamin did not depend on the nature of the salt administered.
Synthesis of L-ascorbic acid froM D-glucuronolactone and L-gulonolactone by rat liver homogenates. The formation of L-ascorbic acid from D-glucuronolactone and L-gulonolactone by liver homogenates of rats fed on a diet supplemented with molybdenum has been studied and the results are presented in Table 2 . From the results in Table 2 it can be calculated that there was a significant decrease in the synthesis of L-ascorbic acid from D-glucuronolactone by the liver tissues of rats fed on diets containing molybdenum either as sodium molybdate (1000p.p.m. and 5000p.p.m.) or as ammonium molybdate (1750p.p.m.). The P values were <0-001, <0-01 and <0-001 respectively. The synthesis of L-ascorbic acid from L-gulonolactone t Not significantly different from the controls. Table 3 . Effect of dietary molybdenum on the cataboliem of L-a8corbic acid by rat liver dehydroa8corbatae
The conditions are given in the Methods section or the preceding paper (Mukherjee et al. 1968 The conditions are given in the Methods section or the preceding paper (Mukherjee et al. 1968 The conditions are given in the Methods section or the preceding paper (Mukherjee et al. 1968 in vitro by the tissues from molybdenum-fed animals was not affected appreciably. Formation of 2,3-dioxogulonic acid from dehydroa8corbic acid by rat liver homogenate8. The data on the effect of molybdenum on the formation of 2,3-dioxogulonic acid from dehydroascorbic acid by liver dehydroascorbatase are presented in Table 3 . It can be seen that high intakes of molybdenum (5000p.p.m. and 7000p.p.m.) markedly inhibited the activity of dehydroascorbatase. The P values were both <0 001.
Conver8ion of D-glucuronolactone into D-glucuronic acidbyratliveruronolactona8e. Dietarymolybdenum at a concentration of 7000p.p.m. was inhibitory to the conversion of D-glucuronolactone into its free acid by the action of rat liver uronolactonase. The results are presented in Table 4 .
Synthe8is of L-xylu108e from 8odium L-gulonate by rat kidney homogenate8. Table 5 shows that molybdenum supplementation of the basal diet did not appreciably alter the activities of L-gulonate dehydrogenase and L-gulonate decarboxylase, which catalyse the conversion of sodium L-gulonate into L-xylulose in the presence of NAD.
Urinary excretion of molybdenum, ascorbic acid and glucuronic acid. The data on the excretion of molybdenum, ascorbic acid and glucuronic acid in urine ofrats given a high dose of molybdenum are Vol. 106N. SASMAL, N. C. KAR, D. MIJKHERJEE AND G. C. CHATTERJEE Table 6 . Effect of molybdenum inge8tion on the urinary excretion of molybdenum, ascorbic acid and glucuronic acid in rats The conditions and methods are given in the Methods section or the preceding paper (Mukherjee et al. 1968 Glucuronic acid 3-38+0-85 (9) 1-35+0-49 (7) 1*84+0-49 (6) 2*68+0-30 (4) Table 7 . Effect of addition of molybdenum in vitro on the 8ynthe8i8 and degradation of L-a8corbic acid by rat liver homogenate8 The conditions are given in the Methods section or the preceding paper (Mukherjee et al. 1968 Table 6 . Inclusion of molybdenum in the diet increased the molybdenum content of urine and decreased the excretion of both ascorbic acid and glucuronic acid in the urine of rats. Effect of addition of molybdenum in vitro on the 8ynthe8i8 and the degradation of L-ascorbic acid by rat liver enzyme8. In an attempt to pinpoint the exact enzymic step affected by dietary molybdenum, the effect of addition of varying amounts of molybdenum as sodium molybdate in vitro on the synthesis and the degradation of L-ascorbic acid has been studied. The results are presented in Table 7 . In contrast with the decreased ascorbic acid-synthesizing capacity of liver tissues in molybdenum-fed rats, the addition of molybdenum in vitro to the reaction mixture containing normal rat liver homogenate failed to elicit any significant alteration in ascorbic acid synthesis. But the liver dehydroascorbatase which catalyses the conversion of dehydroascorbic acid into 2,3-dioxogulonic acid was found to be significantly inhibited by the addition of molybdenum (500,ujg.) in vitro to the reaction medium.
DISCUSSION
The toxicity of excess of dietary molybdenum in rats has been demonstrated before by various workers (Neilands, Strong & Elvehjem, 1948; Gray & Ellis, 1950; Jeter & Davis, 1954) . The data presented in the present paper indicate that tolerance to molybdenum is affected by the chemical form in which the mineral is administered.
Molybdenum ingested as ammonium molybdate is more toxic than sodium molybdate at lower intakes (500p.p.m.). The reason for the greater toxicity of ammonium molybdate is not clear.
The data presented in the present paper indicate that molybdenosis results in diminished reserves of ascorbic acid in liver, kidney and brain, with a corresponding rise in spleen and adrenal gland. Some of these results seem to be at variance with those reported by Malevannaya (1963) , who noted an increased ascorbic acid content in the liver of rats receiving excess of molybdenum. The discrepancy may be attributed to the difference in the mode of administration ofmolybdenum and the type ofbasal ration used.
High intake of molybdenum is found to exert a differential effect on the synthesis of L-ascorbic acid. The conversion of D-glucuronolactone into L-ascorbic acid by rat liver is significantly inhibited, whereas the synthesis of L-ascorbic acid from L-gulonolactone is not altered appreciably. Molybdenum also inhibits the oxidative breakdown of ascorbic acid. The synthesis of L-xylulose by rat 1968 636 Vol. 106 MOLYBDENUM AND ASCORBIC ACID METABOLISM 637 kidney enzymes, however, is not affected. The results indicate that molybdenum interferes with some aspects of ascorbic acid metabolism in rats.
The fact that addition of molybdenum in vitro to the reaction mixture containing normal rat liver homogenate results in an inhibition of the activity of dehydroascorbatase agrees quite well with the results obtained in experiments with molybdenumfed rats in vivo. The result that the synthesis of L-ascorbic acid from D-glucuronolactone by normal rat liver enzymes is not inhibited by the addition of molybdenum to the incubation medium indicates its involvement in this process in some indirect manner, the exact nature of which is not known. From the results presented in the present paper it can be concluded that molybdenum does not augment the synthesis of L-ascorbic acid at all in the animal system, though an increase in the tissue reserves in spleen and adrenal gland has been observed. This contradicts the earlier suggestion put forward by Russian workers (Malevannaya, 1963) , on the basis of increased tissue concentrations of ascorbic acid, that dietary molybdenum stimulates the synthesis of L-ascorbic acid.
